{"ok":true,"trend":{"id":420416,"platform":"news","region":"global","key":"forge, tecpr2 research foundation strike aav gene therapy development, manufacturing partnership","title":"Forge, TECPR2 Research Foundation Strike AAV Gene Therapy Development, Manufacturing Partnership","url":"https://news.google.com/rss/articles/CBMi1wFBVV95cUxPdDBLMkZnMmMtaWhrV0tpdWF4ZWVlVHlnc0l5RDB5YTVEd3ZQVkR0b0xQNzY4RE5jZUxIbFR3NkYybjZMV1Y1MEFEcTJINmJBUWFKSHBaMHhpNVhVZFVnMDgxX1V0eVliX3V1MW0zTUlFaTktU2xVSWlyVXVKZ1BlRHQ5SE9VaXNlSTRpWUY4bi1laTYxNzk5QU9CSUt4ekNVYjNOTmNJYmt6dTl0VnZreTBFVHJMTTRGTFNMX2h3QzdSeXZydUVZQVpOTDh4eHNxcGw5dWhyVQ?oc=5","first_seen":"2026-09-30T00:31:09.795355Z","last_seen":"2026-09-30T00:31:09.795355Z","last_rank":29,"peak_rank":29,"last_volume":null,"peak_volume":null,"seen_count":1,"score":0.7184375,"category_hint":"labor","section":"business","category":"labor","summary":"Forge Biologics and the TECPR2 Research Foundation have announced a partnership covering the development and manufacturing of AAV-based gene therapy, aimed at advancing potential treatments for TECPR2-related genetic disorders. The deal combines Forge's manufacturing capabilities with the foundation's research focus, and observers in the biotech industry are watching it as a further example of nonprofits teaming up with contract manufacturers to accelerate rare-disease therapy programs.","why":"The new partnership announcement is fresh news of interest to the gene therapy and rare-disease community.","tone":"positive","entities":["Forge Biologics","TECPR2 Research Foundation"],"summarized_at":"2026-09-30T00:32:54.544895Z","meta":{"via":"scan","lang":"en","term":"strike","source":"Contract Pharma","published":"Tue, 29 Sep 2026 18:24:27 GMT"},"nw":null,"promo":null,"kind":null,"importance":null,"hidden":false,"hide_reason":null,"judged_at":null,"title_en":"Forge and TECPR2 Foundation Partner on AAV Gene Therapy","section_name":"Business","category_name":"Labor","timeline":[{"captured_at":"2026-09-30T00:31:09.795355Z","rank":29,"volume":null}],"posts":[{"platform":"news","url":"https://news.google.com/rss/articles/CBMi1wFBVV95cUxPdDBLMkZnMmMtaWhrV0tpdWF4ZWVlVHlnc0l5RDB5YTVEd3ZQVkR0b0xQNzY4RE5jZUxIbFR3NkYybjZMV1Y1MEFEcTJINmJBUWFKSHBaMHhpNVhVZFVnMDgxX1V0eVliX3V1MW0zTUlFaTktU2xVSWlyVXVKZ1BlRHQ5SE9VaXNlSTRpWUY4bi1laTYxNzk5QU9CSUt4ekNVYjNOTmNJYmt6dTl0VnZreTBFVHJMTTRGTFNMX2h3QzdSeXZydUVZQVpOTDh4eHNxcGw5dWhyVQ?oc=5","author":"Contract Pharma","title":"Forge, TECPR2 Research Foundation Strike AAV Gene Therapy Development, Manufacturing Partnership","snippet":null,"posted_at":"2026-09-29T18:24:27Z","likes":null}],"elsewhere":[],"window":"7d"}}